Plurilock Security Inc. | Twitter
  • Plurilock (PLUR) appoints Blake Corbet to its Board of Directors while granting stock options
  • Corbet’s experience spans over 25 years, which he spent in investment banking and executive experience
  • Corbet focused his time on specializing in the technology sector
  • Corbet currently works as the Chief Corporate Development Officer at BBTV Holdings, a leading media and technology company
  • Plurilock has granted an option for Corbet to purchase 300,000 common shares at $0.15 per share
  • Plurilock Security (PLUR) is up 8 per cent at close, trading at C$0.14

The duo-listed cybersecurity solutions provider, Plurilock Security (PLUR), appoints Blake Corbet to its Board of Directors.

Corbet’s experience spans over 25 years, which he spent in investment banking and corporate executive experience.

During his tenure as an investment banker, Corbet focused on specializing in the technology sector.

Fast forward to the present day, and you can find Corbet working as the Chief Corporate Development Officer at BBTV Holdings, a leading media and technology company.

Plurilock has granted an option for Corbet to purchase 300,000 common shares at $0.15 per share. The common shares will vest over four years from the grant date.

The stock options are granted for a 10-year term from January 31, 2023.

“We are delighted to appoint Blake Corbet to our Board of Directors,” said Robert Kiesman, Chairman of Plurilock.

“In 2020, [Corbet] assisted Plurilock with its go-public process; as a result, he has in-depth knowledge of our technology and business model. We look forward to continuing our efforts in scaling up the company under his expert guidance,” concluded Kiesman.

Plurilock provides identity-centric cybersecurity for today’s workforces.

Plurilock Security (PLUR) is up 8 per cent at close, trading at C$0.14.


More From The Market Online
stock market down

@ the Bell: Industrials weakness snaps TSX win streak

Industrials led decliners, followed by financials, to snap the TSX’s five-day win streak while energy, utilities and mining provided gains.

Theralase advances cancer research after private placement

Theralase Technologies (TSXV:TLT) closes a non-brokered private placement offering of 4.1 million shares for gross proceeds of C$750,200.